GLIMPZY-MP1 SR
-Tablets.jpg "GLIMPZY-MP1 SR")
Glimepiride, Pioglitazone & Metformin Hydrochloride (Prolonged Release) Tablets
Brand :- GLIMPZY-MP1 SR
Pack Size : 20X10
Pack Type : B/P
Composition :
GLIMEPIRIDE 1MG + METFORMIN HYDROCHLORIDE 500MG (PR) + PIOGLITAZONE 15MG TABLETS
Description :
GLIMPZY-MP1 SR Tablets contain Glimepiride 1 mg, Metformin Hydrochloride 500 mg (Prolonged Release), and Pioglitazone 15 mg, a triple combination used for the effective management of type 2 diabetes mellitus. Glimepiride stimulates insulin release from the pancreas, Metformin reduces glucose production in the liver and improves insulin sensitivity, while Pioglitazone enhances the body’s response to insulin. The prolonged-release formulation provides gradual drug absorption for sustained blood sugar control. This combination helps maintain stable glucose levels and supports better metabolic balance when taken under medical supervision
Products
-&-Voglibose-0.3-mg-Tablets.jpg "GLYZORLLY-MV 0.3")
-&-Voglibose-0.2-mg-Tablets.jpg "GLYZORLLY-MV 0.2")
-and-Metformin-Hydrochloride-(Sustained-Release)-Tablets.jpg "GLYZORLLY-60M")
-Tablets.jpg "GLIMPZY-MP2 SR")
-Tablets-IP.jpg "GLIMPZY-MF1 500SR")
-Tablets.jpg "GLIMPZY-MF1 1000 SR")
-TABLETS.jpg "GLIMPZY-MF2/1000SR")
-Tablets-(450-mg-Diosmin-+-50-mg-Hesperidin).jpg "DAFLOFINE 500 mg")
-Tablets.jpg "DAPAGLYFORD-5M FORTE")
-Tablets.jpg "DAPAGLYFORD-M 10/500SR")
-Tablets.jpg "DAPAGLYFORD-10M FORTE")
-Tablets.jpg "DAPAGLYFORD-GM1 XR")
-Tablets.jpg "DAPAGLYFORD-GM2 XR")
-Tablets.jpg "DAPAGLYFORD-M 5/500SR")
-1000-mg-Tablets.jpg "Sitablast DM Forte")
-500-mg-Tablets.jpg "Sitablast DM")
-Tablets.jpg "SITABLAST-M SR 50/500")
-500-mg,-Glimepiride-1-mg-&-Voglibose-0.3-mg-Tablets.jpg "ORLLYMET-GV 1.3 Billyford")
-1000-mg-Tablets.jpg "Tenoliglipt-M 20/1000")
ORLLYFORD